International Journal of Cardiology
Volume 139, Issue 2 , Pages 134-141 , 4 March 2010

Paracrine effects of CD34 progenitor cells on angiogenic endothelial sprouting

  • Robert J. Scheubel

      Affiliations

    • Department of Cardiothoracic Surgery, Martin Luther University Halle-Wittenberg, Halle (Saale), Germany
    • Corresponding Author InformationCorresponding author. Klinik für Herz- und Thoraxchirurgie, Martin-Luther-Universitaet Halle-Wittenberg, Ernst-Grube-Str. 40, D-06097 Halle (Saale), Germany. Tel.: +49 0345 5572719; fax: +49 0345 5572782.
    • ,
  • Juergen Holtz

      Affiliations

    • Institute of Pathophysiology, Martin Luther University Halle-Wittenberg, Halle (Saale), Germany
    • ,
  • Ivar Friedrich

      Affiliations

    • Department of Cardiothoracic Surgery, Martin Luther University Halle-Wittenberg, Halle (Saale), Germany
    • ,
  • Jochen Borgermann

      Affiliations

    • Department of Cardiothoracic Surgery, Martin Luther University Halle-Wittenberg, Halle (Saale), Germany
    • ,
  • Simone Kahrstedt

      Affiliations

    • Department of Cardiothoracic Surgery, Martin Luther University Halle-Wittenberg, Halle (Saale), Germany
    • ,
  • Alexander Navarrete Santos

      Affiliations

    • Department of Cardiothoracic Surgery, Martin Luther University Halle-Wittenberg, Halle (Saale), Germany
    • ,
  • Rolf-Edgar Silber

      Affiliations

    • Department of Cardiothoracic Surgery, Martin Luther University Halle-Wittenberg, Halle (Saale), Germany
    • ,
  • Andreas Simm

      Affiliations

    • Department of Cardiothoracic Surgery, Martin Luther University Halle-Wittenberg, Halle (Saale), Germany

Received 28 February 2008 ,Revised 4 August 2008 ,Accepted 12 October 2008.

References 

  1. Hristov M, Heussen N, Schober A, Weber C. Intracoronary infusion of autologous bone marrow cells and left ventricular function after acute myocardial infarction: a meta-analysis. J Cell Mol Med. 2006;10:727–733
  2. Aicher A, Rentsch M, Sasaki K, et al. Nonbone marrow-derived circulating progenitor cells contribute to postnatal neovascularization following tissue ischemia. Circ Res. 2007;100:581–589
  3. Heil M, Ziegelhoeffer T, Mees B, Schaper W. A different outlook on the role of bone marrow stem cells in vascular growth: bone marrow delivers software not hardware. Circ Res. 2004;94:573–574
  4. de Muinck ED, Simons M. Re-evaluating therapeutic neovascularization. J Mol Cell Cardiol. 2004;36:25–32
  5. Hickey MM, Simon MC. Regulation of angiogenesis by hypoxia and hypoxia-inducible factors. Curr Top Dev Biol. 2006;76:217–257
  6. Simon MC, Liu L, Barnhart BC, Young RM. Hypoxia-induced signaling in the cardiovascular system. Annu Rev Physiol. 2008;70:51–71
  7. Ceradini DJ, Gurtner GC. Homing to hypoxia: HIF-1 as a mediator of progenitor cell recruitment to injured tissue. Trends Cardiovasc Med. 2005;15:57–63
  8. Majka M, Janowska-Wieczorek A, Ratajczak J, et al. Numerous growth factors, cytokines, and chemokines are secreted by human CD34(+) cells, myeloblasts, erythroblasts, and megakaryoblasts and regulate normal hematopoiesis in an autocrine/paracrine manner. Blood. 2001;97:3075–3085
  9. Korff T, Kimmina S, Martiny-Baron G, Augustin HG. Blood vessel maturation in a 3-dimensional spheroidal coculture model: direct contact with smooth muscle cells regulates endothelial cell quiescence and abrogates VEGF responsiveness. Faseb J. 2001;15:447–457
  10. Kawamoto A, Iwasaki H, Kusano K, et al. CD34-positive cells exhibit increased potency and safety for therapeutic neovascularization after myocardial infarction compared with total mononuclear cells. Circulation. 2006;114:2163–2169
  11. Scheubel RJ, Kahrstedt S, Weber H, et al. Depression of progenitor cell function by advanced glycation endproducts (AGEs): potential relevance for impaired angiogenesis in advanced age and diabetes. Exp Gerontol. 2006;41:540–548
  12. Calvani M, Rapisarda A, Uranchimeg B, Shoemaker RH, Melillo G. Hypoxic induction of an HIF-1alpha-dependent bFGF autocrine loop drives angiogenesis in human endothelial cells. Blood. 2006;107:2705–2712
  13. Annabi B, Lee YT, Turcotte S, et al. Hypoxia promotes murine bone-marrow-derived stromal cell migration and tube formation. Stem Cells. 2003;21:337–347
  14. Kidszun A, Schneider D, Erb D, et al. Isolated pancreatic islets in three-dimensional matrices are responsive to stimulators and inhibitors of angiogenesis. Cell Transplant. 2006;15:489–497
  15. Munk VC, Sanchez de Miguel L, Petrimpol M, et al. Angiotensin II induces angiogenesis in the hypoxic adult mouse heart in vitro through an AT2-B2 receptor pathway. Hypertension. 2007;49:1178–1185
  16. Li TS, Hamano K, Suzuki K, Ito H, Zempo N, Matsuzaki M. Improved angiogenic potency by implantation of ex vivo hypoxia prestimulated bone marrow cells in rats. Am J Physiol Heart Circ Physiol. 2002;283:H468–H473
  17. O'Neill TJ, Wamhoff BR, Owens GK, Skalak TC. Mobilization of bone marrow-derived cells enhances the angiogenic response to hypoxia without transdifferentiation into endothelial cells. Circ Res. 2005;97:1027–1035
  18. Carmeliet P. Mechanisms of angiogenesis and arteriogenesis. Nat Med. 2000;6:389–395
  19. Tse HF, Siu CW, Zhu SG, et al. Paracrine effects of direct intramyocardial implantation of bone marrow derived cells to enhance neovascularization in chronic ischaemic myocardium. Eur J Heart Fail. 2007;9:747–753
  20. Li A, Varney ML, Valasek J, Godfrey M, Dave BJ, Singh RK. Autocrine role of interleukin-8 in induction of endothelial cell proliferation, survival, migration and MMP-2 production and angiogenesis. Angiogenesis. 2005;8:63–71
  21. Ogawa S, Yoshida S, Ono M, et al. Induction of macrophage inflammatory protein-1alpha and vascular endothelial growth factor during inflammatory neovascularization in the mouse cornea. Angiogenesis. 1999;3:327–334
  22. Caux C, Ait-Yahia S, Chemin K, et al. Dendritic cell biology and regulation of dendritic cell trafficking by chemokines. Springer Semin Immunopathol. 2000;22:345–369
  23. Nilsson MB, Langley RR, Fidler IJ. Interleukin-6, secreted by human ovarian carcinoma cells, is a potent proangiogenic cytokine. Cancer Res. 2005;65:10794–10800
  24. Hong KH, Ryu J, Han KH. Monocyte chemoattractant protein-1-induced angiogenesis is mediated by vascular endothelial growth factor-A. Blood. 2005;105:1405–1407
  25. Vandervelde S, van Luyn MJ, Rozenbaum MH, Petersen AH, Tio RA, Harmsen MC. Stem cell-related cardiac gene expression early after murine myocardial infarction. Cardiovasc Res. 2007;73:783–793
  26. Chen CP, Lee YJ, Chiu ST, et al. The application of stem cells in the treatment of ischemic diseases. Histol Histopathol. 2006;21:1209–1216
  27. Sharma R, Raghubir R. Stem cell therapy: a hope for dying hearts. Stem Cells Dev. 2007;16:517–536
  28. Takahashi K, Tanabe K, Ohnuki M, et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell. 2007;131:1–12
  29. Laflamme MA, Chen KY, Naumova AV, et al. Cardiomyocytes derived from human embryonic stem cells in pro-survival factors enhance function of infarcted rat hearts. Nat Biotechnol. 2007;25:1015–1024
  30. Meyer GP, Wollert KC, Lotz J, et al. Intracoronary bone marrow cell transfer after myocardial infarction: eighteen months' follow-up data from the randomized, controlled BOOST (BOne marrOw transfer to enhance ST-elevation infarct regeneration) trial. Circulation. 2006;113:1287–1294
  31. Laflamme MA, Zbinden S, Epstein SE, Murry CE. Cell-based therapy for myocardial ischemia and infarction:pathological mechanisms. Annu Rev Pathol Mech Dis. 2007;2:307–339
  32. Reffelmann T, Dow JS, Dai W, Hale SL, Simkhovich BZ, Kloner RA. Transplantation of neonatal cardiomyocytes after permanent coronary artery occlusion increases regional blood flow of infarcted myocardium. J Mol Cell Cardiol. 2003;35:607–613
  33. Coats AJ. Ethical authorship and publishing. Int J Cardiol. 2009;131:149–150

PII: S0167-5273(08)01067-X

doi: 10.1016/j.ijcard.2008.10.009

International Journal of Cardiology
Volume 139, Issue 2 , Pages 134-141 , 4 March 2010

Article Tools

* Image Usage & Resolution